ARTICLE | Clinical News
Guilford regulatory update
May 10, 1999 7:00 AM UTC
GLFD received four U.S. Patents. Nos. 5,859,031 and 5,874,449 cover small molecule FKBP-neuroimmunophilin ligands to treat and prevent neurodegenerative disorders such as Parkinson's disease and Alzhe...